{"title":"Quinoline–sulfonamides as a multi-targeting neurotherapeutic for cognitive decline: in vitro, in silico studies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D3RA05501A","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D3RA05501A\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,8905-8920<br /><b>DOI</b>: 10.1039/D3RA05501A, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Saquib Jalil, Zahid Hussain, Syed Mobashir Ali Abid, Abdul Hameed, Jamshed Iqbal<br />Alzheimer's disease (AD) is a multifactorial irreversible neurological disorder with multiple enzymes involved.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"5f025906c91d1c3139b3826d9fa926f0bb4d86ecf13d2a2742f9f8ce28e22201","category":"Environment"}